乌鸦传媒

Landmark trials establish a new standard of care, experts say

Large observational study might not deliver definitive answers but hints at a better strategy

Lytic at least appeared safe in a selected population with many undergoing thrombectomy

Trial from China shows potential of AI guidance for stroke care

TREND trial compares acute antiplatelet monotherapies

Small single-center trial suggests time delays will be a critical hurdle

Pooled trial analysis finally provides the evidence for combination approach

Phase III trial is the "disappointing end of a long journey"

MARVEL trial tries adjunctive therapy again with new circumstances but gets the same old answer

Tilting the head of the bed up during early window in large vessel occlusion hurts outcomes

DAPT turns in non-inferior results versus IV alteplase in ARAMIS trial from China

Chinese trial supports stronger antiplatelet for patients ineligible for lytics, thrombectomy

Among six interventions, uric acid exceeded efficacy boundaries

Pair of phase III trials lay the groundwork for expanding indication